SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022812
Filing Date
2020-05-07
Accepted
2020-05-07 16:01:28
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q igms-10q_20200331.htm 10-Q 2034011
2 EX-31.1 igms-ex311_10.htm EX-31.1 19007
3 EX-31.2 igms-ex312_8.htm EX-31.2 17500
4 EX-32.1 igms-ex321_13.htm EX-32.1 9501
5 EX-32.2 igms-ex322_12.htm EX-32.2 9496
  Complete submission text file 0001564590-20-022812.txt   6270084

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT igms-20200331.xml EX-101.INS 1213943
7 XBRL TAXONOMY EXTENSION SCHEMA igms-20200331.xsd EX-101.SCH 42323
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE igms-20200331_cal.xml EX-101.CAL 44974
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igms-20200331_def.xml EX-101.DEF 181357
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20200331_lab.xml EX-101.LAB 353859
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20200331_pre.xml EX-101.PRE 282241
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 20856170
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences